June 13th: From Idea to Bench to Bedside – a Biomedical Innovation Summit

Medical Innovation:

 From Idea to Bench to Bedside

A Biomedical Innovation Summit

Dan Panorama Tel Aviv ¡ Sunday, June 13, 2010

 

 

Presented by

Cleveland Clinic

Global Cardiovascular Innovation Center

Israel Life Sciences Industries

 

And Sponsored By

GT Greenberg Traurih, MPR, PriceWaterhouseCoopers, Team Neo, Cleveland Plus Business

       

Program

8:45                 Registration, Breakfast, Networking

9:15                 Welcome and Introductions

                        Ruti Alon, Chair ILSI

                        Mark Low, Global Cardiovascular Innovation Center

                        Richard Schottenstein, The Ohio Department of Development

9:30                 How new products are conceived and developed

                        Yossi Gross, Israel most prolific biotech innovator

                        Guy Shinar, Medical Device Entrepreneur

10:30               The Future of Innovation in the US–What is the Market Looking For

                        Laurence Kennedy, MD of Endocrinology, Diabetes, and Metabolism Department, Cleveland Clinic

                       Mark Low, Managing Director, Global Cardiovascular Innovation Center

                        Philip R. Schauer, MD, Chief of Minimally Invasive General Surgery and Director Bariatric and Metabolic Institute Cleveland Clinic

                        Rishi Singh, MD, Department of Ophthalmology, Cleveland Clinic

12:30               Lunch

13:30               KEYNOTE

                        Case Study in Medical Innovation

                        Israeli Companies and the US Market

                        Avshalom Horan, Chairman Simbionix                                                            

                        Avner Halperin, CEO Early Sense

                        Amir Ronen, CEO Sensible Medical Innovation

14:15               Design, Development, Engineering                                            

                        A Proven Process of Product Development                             

                        Christian Haller, MPR, Inc

14:45               From IP to FDA; FROM IDEA TO COMPANY

                        Understanding the legal Landscape

                        Robert Grossman, Partner Greenberg Traurig, LLP.

15:30               The “Business of Innovation”

                        Claudio Yarza, PricewaterhouseCoopers, Israel

16:00               Funding, Funding, Funding: Key throughout the process

                        Ruti Alon, General  Partner Pitango Venture Capital

                        Michael Goldberg, Managing Partner Bridge Investment Fund

                        Mark Low, Global Cardiovascular Innovation Center

                        Dalia Megiddo, Managing Partner 7 health Ventures

                        Richard Schottenstein, The Ohio Department of Development

                        Neil Wyant, FirHill LLC – Venture arm of the Kanfer Family

                         

17:00               Working in North America

                        From Clinical Relationships to Corporate Partnerships

                        Everything you Wanted to Know, but did not Know Whom to Ask

                        Mark Low, Global Cardiovascular Innovation Center

                        Laurence Kennedy, MD, Chairman of Endocrinology, Diabetes, and Metabolism Department, Cleveland Clinic

                        Philip R. Schauer, MD, Chief of Minimally Invasive General Surgery and Director Bariatric and Metabolic Institute Cleveland Clinic

                        Rishi Singh, MD, Department of Ophthalmology, Cleveland Clinic

17:45               WRAP

 

18:00               NETWORKING RECEPTION

Popularity: 62% [?]

Share this Post:
Digg Google Bookmarks reddit Mixx StumbleUpon Technorati Yahoo! Buzz DesignFloat Delicious BlinkList Furl

491 Responses to “June 13th: From Idea to Bench to Bedside – a Biomedical Innovation Summit”

Trackbacks are disabled.

quickly
1 8 9 10